Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Increasing physical endurance with salmeterol]

E Schmitz1, T Hürter, J G Ochs

  • 1Medizinsiche Klinik I, Universitätsklinik (RWTH) Aachen.

Pneumologie (Stuttgart, Germany)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of Same-Sign WW Production from Double Parton Scattering in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2023
Same author

Measurements of jet multiplicity and jet transverse momentum in multijet events in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

Search for Higgs Boson Decay to a Charm Quark-Antiquark Pair in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2023
Same author

Azimuthal Correlations within Exclusive Dijets with Large Momentum Transfer in Photon-Lead Collisions.

Physical review letters·2023
Same author

Azimuthal correlations in Z +jets events in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

Search for Nonresonant Pair Production of Highly Energetic Higgs Bosons Decaying to Bottom Quarks.

Physical review letters·2023
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

Salmeterol significantly improves exercise capacity in COPD patients by enhancing ventilation. This long-lasting effect was observed up to 7 hours post-inhalation without adverse cardiovascular changes.

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Exercise Physiology

Context:

  • Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by airflow limitation.
  • Patients often experience reduced exercise capacity and quality of life.
  • Salmeterol is a long-acting beta-agonist (LABA) used in COPD management.

Purpose:

  • To evaluate the effects of inhaled salmeterol on lung function and exercise capacity in COPD patients.
  • To assess the duration of salmeterol's efficacy.
  • To determine if salmeterol impacts cardiovascular parameters during exercise.

Summary:

  • Ten patients with mild to moderate COPD received 50 micrograms of salmeterol.
  • Lung function tests and spiroergometry were performed before and 1, 7 hours after inhalation.

Related Experiment Videos

  • Significant improvements were noted in forced expiratory volume in 1 second (FEV1), airway resistance, and various exercise capacity parameters, including work capacity, oxygen consumption, and ventilation at the anaerobic threshold (AT) and maximum levels.

    • Impact:

    • Salmeterol provides a sustained improvement in exercise capacity for COPD patients.
    • The enhanced exercise tolerance is attributed to improved ventilation.
    • The study indicates salmeterol is safe for exercise in COPD, with no significant changes in heart rate or blood pressure.